Logo
M

Mestag Therapeutics

56 employees

Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for inflammatory disease and cancer. Through our unique understanding of fibroblast immunology, we are advancing a pipeline of first-in-class antibody programs and targets for new treatments. Backed by committed leading global investors, world-class founders and a highly experienced leadership team, Mestag offers an exciting, diverse and balanced place to work, with competitive benefits, generous vacation time and the room to grow and develop your career. Show more Show less

Investor insights

Funding rounds participated in

$2M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2020

Funding rounds raised

Total raised

$2M

from 1 investors over 1 rounds

M

Mestag Therapeutics raised $2M on September 28, 2024

Investors: Innovate UK

FAQ